Model-Based Analysis of Continuous Crystallization/Reaction Processes Separating Conglomerate Forming Enantiomers

Köllges, Till; Vetter, Thomas

doi:10.1021/acs.cgd.6b01487

Cited by 36 publications

(56 citation statements)

References 57 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Traditionally, this may have been difficult to implement industrially in the pharmaceutical industry which has almost exclusively utilized standard batch equipment. However, the past decade has seen a significant uptake of crystallizer technologies for use in next generation continuous pharmaceutical platforms with ability to separate enantiomers in a continuous manner as well as access to a wider ranges of particle sizes, improved polymorph control, and increased purity …”

Section: Introductionmentioning

confidence: 99%

Diastereomeric salt crystallization of chiral molecules via sequential coupled‐Batch operation

et al. 2018

View full text Add to dashboard Cite

A novel process, sequential coupled‐batch diastereomeric crystallization is presented for the resolution of racemic mixtures. This strategy utilized a preferential crystallization of diastereomeric salt followed by sequential coupled diastereomeric salt resolution of racemic ibuprofen with the resolving agent (S)‐lysine utilizing a novel small scale pneumatic liquid exchange design to couple two batch crystallizers. Results were compared to conventional sequential resolution via seeded isothermal batch crystallization. Diastereomeric salt resolution was developed using the ternary phase diagram of the isolated (R)‐ibuprofen‐(S)‐lysine and (S)‐ibuprofen‐(S)‐lysine salts and optimized empirically with the aid of process analytical technology. Sequential coupled‐batch crystallization was found to be capable of increasing the yield of both salts while maintaining purity. This gave an increase in both the productivity and yield (20.5% for (S)‐ibuprofen‐(S)‐lysine) compared to the equivalent sequential batch (17.7% for (S)‐ibuprofen‐(S)‐lysine) crystallization methodology. Single crystals of the (S)‐ibuprofen‐(S)‐lysine were isolated, and its single crystal structure determined. © 2018 American Institute of Chemical Engineers AIChE J, 65: 604–616, 2019

show abstract

Section: Introductionmentioning

confidence: 99%

Diastereomeric salt crystallization of chiral molecules via sequential coupled‐Batch operation

et al. 2018

View full text Add to dashboard Cite

show abstract

“…Monte Carlo simulations 35,[42][43][44] , dispersive kinetic models 45 and population balance models [46][47][48][49] .…”

Section: Introductionmentioning

confidence: 99%

Coupling Viedma Ripening with Racemic Crystal Transformations: Mechanism of Deracemization

Xiouras

Horst

Gerven

et al. 2017

Crystal Growth & Design

View full text Add to dashboard Cite

It has been recently observed that coupling Viedma ripening with a seeded in-situ metastable racemic crystal to conglomerate transformation leads to accelerated and complete deracemization: crystal transformation-enhanced deracemization. By means of a simple kinetic model, we show that the mechanistic pathway of this new process depends profoundly on the interplay between the crystal transformation and racemization processes, which in turn influence the nucleation process of the counter enantiomer. If the nucleation of the counter enantiomer is suppressed (e.g. by sufficiently fast racemization, low amount of racemic compound or gradual feed, low relative solubility between racemic compound and conglomerate), deracemization proceeds via a second order asymmetric transformation (SOAT) and is limited primarily by the dissolution rate of the racemic crystals and the growth rate of the preferred enantiomer crystals. Breakage and agglomeration accelerate the process, but contrary to conventional Viedma ripening, they are not essential ingredients to explain the observed enantiomeric enrichment. If the nucleation process of the counter enantiomer is not sufficiently suppressed, deracemization is initially controlled by the dissolution rate of the racemic crystals, but Viedma ripening is subsequently required to convert the conglomerate crystals of the counter enantiomer formed by nucleation, resulting in slower deracemization kinetics. In both cases, the combined process leads to faster deracemization kinetics compared to conventional Viedma ripening, while it autocorrects for the main disadvantage of SOAT, i.e. the accidental nucleation of the counter enantiomer. In addition, crystal transformation-enhanced deracemization extends the range of applicability of solid-state deracemization processes to compounds that form metastable racemic crystals. interplay between the crystal transformation and racemization processes, which in turn influence the nucleation process of the counter enantiomer. If the nucleation of the counter enantiomer is 3 suppressed (e.g. by sufficiently fast racemization, low amount of racemic compound or gradual feed, low relative solubility between racemic compound and conglomerate), deracemization proceeds via a second order asymmetric transformation (SOAT) and is limited primarily by the dissolution rate of the racemic crystals and the growth rate of the preferred enantiomer crystals.Breakage and agglomeration accelerate the process, but contrary to conventional Viedma ripening, they are not essential ingredients to explain the observed enantiomeric enrichment. If the nucleation process of the counter enantiomer is not sufficiently suppressed, deracemization is initially controlled by the dissolution rate of the racemic crystals, but Viedma ripening is subsequently required to convert the conglomerate crystals of the counter enantiomer formed by nucleation, resulting in slower deracemization kinetics. In both cases, the combined process leads to faster deracemization kinetics compared ...

show abstract

“…The symmetry could break spontaneously during the crystallization process, as it was demonstrated for the NaClO 3 solutions if crys- 25 tallization proceeded under stirring [17] or in the presence of some additional components, like glass beads [18,19,20]. The crystallization combined with the milling and a racemization processes could yield products of very high chiral asymmetry, up to 100 % in ideal conditions [21].…”

Section: Introductionmentioning

confidence: 98%

Spontaneous Resolution in Racemic Solutions of N-trifluoroacetylated α-aminoalcohols

Zlenko

Zanin

Скоблин

et al. 2018

Preprint

View full text Add to dashboard Cite

The spontaneous resolution was observed in the racemic solution of Ntrifluoroacetylated α-aminoalcohol (TFAAA-6) in CCl4. In against other cases of the conglomerates formation, the TFAAA-6 forms highly anisometric crystalline structures (strings). Herewith, the spontaneous resolution was not observed in the racemic solution of TFAAA-5 in heptane, where the isometric precipitate was formed. The latter was also observed in the TFAAA-5 solutions in heptane with small enantiomeric excess (EE), down to 2 %. With that, the homochiral strings formed in the TFAAA-5 solutions in heptane with larger EEs. In this case, the strings formed from the excess of one of the enantiomers remained in solution after precipitation of the racemic residual. This process leads to the enhancement of chiral polarization in systems close to racemic and can explain the chiral purity of the living cell.

show abstract

Model-Based Analysis of Continuous Crystallization/Reaction Processes Separating Conglomerate Forming Enantiomers

Cited by 36 publications

References 57 publications

Diastereomeric salt crystallization of chiral molecules via sequential coupled‐Batch operation

Diastereomeric salt crystallization of chiral molecules via sequential coupled‐Batch operation

Coupling Viedma Ripening with Racemic Crystal Transformations: Mechanism of Deracemization

Spontaneous Resolution in Racemic Solutions of N-trifluoroacetylated α-aminoalcohols

Contact Info

Product

Resources

About